- Home
- VYNE vs AMBO Comparison
VYNE vs AMBO Comparison
Compare VYNE & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- AMBO
- Stock Information
- Founded
- VYNE 2003
- AMBO 2000
- Country
- VYNE United States
- AMBO United States
- Employees
- VYNE N/A
- AMBO N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- AMBO Other Consumer Services
- Sector
- VYNE Health Care
- AMBO Real Estate
- Exchange
- VYNE Nasdaq
- AMBO Nasdaq
- Market Cap
- VYNE 7.9M
- AMBO 8.3M
- IPO Year
- VYNE 2018
- AMBO 2010
- Fundamental
- Price
- VYNE $0.30
- AMBO $2.91
- Analyst Decision
- VYNE Buy
- AMBO
- Analyst Count
- VYNE 2
- AMBO 0
- Target Price
- VYNE $8.00
- AMBO N/A
- AVG Volume (30 Days)
- VYNE 1.9M
- AMBO 41.8K
- Earning Date
- VYNE 11-06-2025
- AMBO 08-05-2025
- Dividend Yield
- VYNE N/A
- AMBO N/A
- EPS Growth
- VYNE N/A
- AMBO N/A
- EPS
- VYNE N/A
- AMBO 0.69
- Revenue
- VYNE $476,000.00
- AMBO $9,699,000.00
- Revenue This Year
- VYNE N/A
- AMBO N/A
- Revenue Next Year
- VYNE N/A
- AMBO N/A
- P/E Ratio
- VYNE N/A
- AMBO $4.65
- Revenue Growth
- VYNE N/A
- AMBO 23.73
- 52 Week Low
- VYNE $0.29
- AMBO $1.00
- 52 Week High
- VYNE $4.30
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- VYNE 28.46
- AMBO 42.24
- Support Level
- VYNE $0.32
- AMBO $3.22
- Resistance Level
- VYNE $0.33
- AMBO $3.78
- Average True Range (ATR)
- VYNE 0.02
- AMBO 0.42
- MACD
- VYNE 0.03
- AMBO -0.07
- Stochastic Oscillator
- VYNE 11.44
- AMBO 0.00
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.